Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. TOBRADEX (dexaméthasone/ tobramycine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TOBRADEX (dexaméthasone/ tobramycine)

Medicine - Posted on Mar 18 2021
Active substance (DCI)
  • dexaméthasone
  • tobramycine
history (4)
  • 2/17/21

    TOBRADEX (dexamethasone/ tobramycine)

    Key points Maintenance of the favourable opinion for reimbursement in the local anti-inflammatory and antibacterial treatmen...
    icône flèche
  • 3/9/11

    TOBRADEX (dexaméthasone/ tobramycine)

    TOBRADEX (dexaméthasone/ tobramycine)
    icône flèche
  • 1/31/07

    TOBRADEX (dexaméthasone/ tobramycine)

    TOBRADEX (dexaméthasone/ tobramycine)
    icône flèche
  • 3/21/01

    TOBRADEX, collyre en solution, (flacon de 5 ml)

    TOBRADEX, collyre en solution, (flacon de 5 ml)
    icône flèche
Technical information
ATC code
  • S01CA01
Manufacturer
NOVARTIS PHARMA
Presentation

TOBRADEX, collyre en suspension
Flacon de 5 ml (CIP : 34009 344 299 7 2 4)

All our publications
    Bacterial infections Drug therapy Eye diseases Pain - Inflammation

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
evvxR5B58kBYLpsp